SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Since Jun 07, 2012, SUPERNUS PHARMACEUTICALS, INC. (SUPN) has reported earnings 57 times. On average the shares move ±5.45% post-earnings, with a positive reaction 57.9% of the time. Its largest post-earnings gain was +14.49% (Aug 06, 2024) and its largest decline was -19.71% (Mar 14, 2013). The next earnings report is predicted for 2026-08-12 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
57
Avg Abs. Movement
±5.45%
Positive %
57.9%
Negative %
42.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 05, 2026 | ☽ POST | $49.23 | $50.29 | $49.13 | 43,067 | +4.6% | open_in_new |
| Apr 22, 2026 | ☽ POST | $49.42 | $50.32 | $50.29 | 391,700 | +0.2% | open_in_new |
| Feb 24, 2026 | ☽ POST | $50.95 | $53.68 | $53.30 | 2,208,200 | +5.67% | open_in_new |
| Nov 04, 2025 | ☽ POST | $55.43 | $57.40 | $57.00 | 1,478,900 | -17.35% | open_in_new |
| Aug 05, 2025 | ☽ POST | $36.83 | $37.88 | $37.53 | 1,132,200 | +13.08% | open_in_new |
| May 06, 2025 | ☽ POST | $32.37 | $32.78 | $32.43 | 755,900 | -4.59% | open_in_new |
| Feb 25, 2025 | ☽ POST | $32.84 | $33.50 | $32.81 | 961,700 | -2.74% | open_in_new |
| Nov 04, 2024 | ☽ POST | $33.96 | $34.96 | $34.70 | 450,600 | +0.12% | open_in_new |
| Aug 06, 2024 | ☽ POST | $27.89 | $28.55 | $27.88 | 619,300 | +14.49% | open_in_new |
| May 08, 2024 | ☽ POST | $30.97 | $31.56 | $31.30 | 461,400 | -4.15% | open_in_new |
| Feb 27, 2024 | ☽ POST | $29.71 | $31.56 | $30.69 | 907,800 | +1.27% | open_in_new |
| Nov 08, 2023 | ☽ POST | $23.96 | $24.23 | $23.52 | 491,000 | +11.14% | open_in_new |
| Aug 08, 2023 | ☽ POST | $32.34 | $32.98 | $32.91 | 665,900 | -7.23% | open_in_new |
| May 09, 2023 | ☽ POST | $36.69 | $36.72 | $36.18 | 362,100 | +1.49% | open_in_new |
| Feb 28, 2023 | ☽ POST | $37.81 | $38.21 | $37.59 | 600,300 | +4.42% | open_in_new |
| Nov 08, 2022 | ☽ POST | $34.80 | $34.94 | $34.70 | 555,700 | -5.82% | open_in_new |
| Aug 04, 2022 | ☽ POST | $32.07 | $32.98 | $32.81 | 518,100 | -1.98% | open_in_new |
| May 09, 2022 | ☽ POST | $27.34 | $27.34 | $26.37 | 531,700 | -2.05% | open_in_new |
| Feb 28, 2022 | ☽ POST | $30.82 | $32.57 | $31.95 | 660,500 | -7.04% | open_in_new |
| Nov 04, 2021 | ☽ POST | $32.74 | $32.74 | $31.56 | 877,500 | +2.03% | open_in_new |
| Aug 04, 2021 | ☽ POST | $26.59 | $27.22 | $27.18 | 508,200 | -2.17% | open_in_new |
| May 05, 2021 | ☽ POST | $30.07 | $31.00 | $30.49 | 406,400 | -3.94% | open_in_new |
| Feb 26, 2021 | ☽ POST | $26.58 | $28.50 | $26.87 | 1,701,800 | -3.28% | open_in_new |
| Nov 04, 2020 | ☽ POST | $21.35 | $22.87 | $22.47 | 2,022,500 | +2.49% | open_in_new |
| Aug 19, 2020 | ☽ POST | $25.00 | $25.00 | $23.40 | 857,500 | -3.5% | open_in_new |
| May 07, 2020 | ☀ PRE | $23.67 | $24.69 | $23.33 | 738,300 | +0.69% | open_in_new |
| Feb 27, 2020 | ☽ POST | $19.36 | $19.37 | $18.00 | 992,700 | -0.06% | open_in_new |
| Nov 06, 2019 | ☽ POST | $21.97 | $22.00 | $19.93 | 6,732,100 | +6.12% | open_in_new |
| Aug 06, 2019 | ☽ POST | $32.20 | $33.43 | $33.30 | 547,500 | -14.98% | open_in_new |
| May 07, 2019 | ☽ POST | $38.05 | $38.74 | $36.96 | 1,085,100 | -3.52% | open_in_new |
| Feb 26, 2019 | ☽ POST | $37.20 | $37.58 | $36.88 | 837,700 | +13.86% | open_in_new |
| Nov 06, 2018 | ☽ POST | $41.77 | $42.09 | $41.65 | 1,175,000 | +8.5% | open_in_new |
| Aug 07, 2018 | ☽ POST | $52.95 | $54.70 | $53.35 | 787,400 | -8.72% | open_in_new |
| May 08, 2018 | ☽ POST | $45.20 | $45.35 | $44.65 | 647,200 | +7.39% | open_in_new |
| Feb 27, 2018 | ☽ POST | $38.95 | $39.30 | $38.10 | 759,600 | +2.1% | open_in_new |
| Nov 07, 2017 | ☽ POST | $38.00 | $38.00 | $36.40 | 2,740,900 | +1.37% | open_in_new |
| Aug 02, 2017 | ☽ POST | $40.70 | $41.35 | $40.60 | 604,100 | +2.71% | open_in_new |
| May 09, 2017 | ☽ POST | $31.90 | $33.00 | $32.90 | 1,011,400 | -3.04% | open_in_new |
| Mar 01, 2017 | ☽ POST | $26.10 | $26.75 | $26.00 | 648,000 | +5.38% | open_in_new |
| Aug 02, 2016 | ☽ POST | $22.22 | $22.59 | $22.26 | 577,800 | +2.96% | open_in_new |
| May 04, 2016 | ☽ POST | $15.84 | $16.05 | $15.90 | 808,400 | -1.7% | open_in_new |
| Mar 03, 2016 | ☽ POST | $14.04 | $14.95 | $13.99 | 1,552,800 | +2.79% | open_in_new |
| Nov 04, 2015 | ☽ POST | $18.88 | $20.39 | $18.26 | 1,220,100 | -2.63% | open_in_new |
| Aug 05, 2015 | ☽ POST | $22.34 | $23.30 | $19.22 | 2,546,100 | -3.54% | open_in_new |
| May 05, 2015 | ☽ POST | $13.14 | $13.14 | $12.54 | 491,100 | -1.83% | open_in_new |
| Mar 10, 2015 | ☽ POST | $9.83 | $9.98 | $9.93 | 852,100 | +10.78% | open_in_new |
| Nov 12, 2014 | ☀ PRE | $8.47 | $8.62 | $8.40 | 1,220,600 | +6.19% | open_in_new |
| Aug 11, 2014 | ☽ POST | $8.52 | $8.60 | $8.33 | 484,700 | +8.88% | open_in_new |
| May 13, 2014 | ☽ POST | $7.32 | $7.87 | $7.80 | 381,300 | +1.79% | open_in_new |
| Mar 12, 2014 | ☽ POST | $8.83 | $9.38 | $9.15 | 1,014,300 | +6.67% | open_in_new |
| Nov 12, 2013 | ☽ POST | $6.85 | $7.02 | $6.90 | 559,300 | +8.7% | open_in_new |
| Aug 13, 2013 | ☽ POST | $6.52 | $6.54 | $6.24 | 152,100 | +10.9% | open_in_new |
| May 13, 2013 | ☽ POST | $5.09 | $5.29 | $5.12 | 659,900 | +5.27% | open_in_new |
| Mar 14, 2013 | ☽ POST | $7.14 | $7.21 | $6.90 | 201,700 | -19.71% | open_in_new |
| Nov 08, 2012 | ☽ POST | $11.97 | $12.40 | $12.00 | 43,600 | +1.58% | open_in_new |
| Aug 10, 2012 | ☽ POST | $13.05 | $13.51 | $12.48 | 28,500 | +6.01% | open_in_new |
| Jun 07, 2012 | ☽ POST | $4.87 | $5.39 | $5.24 | 18,600 | -3.24% | open_in_new |
Earnings Count
57
Total earnings in dataset
Avg Abs. Movement
±5.45%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260520 | open_in_new SEC.gov |
| 10-Q | 20260505 | open_in_new SEC.gov |
| 8-K | 20260505 | open_in_new SEC.gov |
| ARS | 20260430 | open_in_new SEC.gov |
| DEF 14A | 20260430 | open_in_new SEC.gov |
| DEFA14A | 20260430 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260430 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260429 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260429 | open_in_new SEC.gov |
| 8-K | 20260422 | open_in_new SEC.gov |
Frequently asked about SUPN earnings
When does SUPERNUS PHARMACEUTICALS, INC. report earnings next? expand_more
SUPERNUS PHARMACEUTICALS, INC. (SUPN)'s next earnings date is approximate for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does SUPN stock move after earnings? expand_more
Over 57 reports, SUPN has moved an average of ±5.45% the session after earnings, closing higher 57.9% of the time.
What was SUPN's biggest post-earnings move? expand_more
SUPN's largest post-earnings gain on record was +14.49% on Aug 06, 2024, and its largest decline was -19.71% on Mar 14, 2013.
Where can I find SUPERNUS PHARMACEUTICALS, INC.'s SEC filings? expand_more
All of SUPERNUS PHARMACEUTICALS, INC.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right